Your browser is no longer supported. Please, upgrade your browser.
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-6.79%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month4.39%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter6.69%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-21.74%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-21.23%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range44.16 - 90.86 Perf YTD-23.18%
Dividend0.45 P/FCF- EPS past 5Y- ROI- 52W High-40.64% Beta-
Dividend %0.83% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low22.12% ATR1.94
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)45.13 Volatility3.01% 3.39%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.28 Prev Close55.16
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume7.51M Price53.93
Recom- SMA20-3.66% SMA502.64% SMA200-16.53% Volume9,611,974 Change-2.23%
Apr-28-16 04:56PM  Is XBI Heading Back to Where It Started in April? Market Realist
03:04AM  Opportunities For Xtandi, Medivations Key Drug Market Realist
Apr-27-16 06:08PM  Energy-Related Stocks Rose after FOMC Decision Market Realist
Apr-25-16 09:00AM  Trader's Notebook: Responding to the Move in Dollar Futures at TheStreet
Apr-22-16 09:00AM  Trader's Notebook: Searching for Bullish Excess in the Banks at TheStreet
Apr-21-16 04:51PM  Rising Dollar Offsets Crude Prices as Major SPDR Indexes Fall Market Realist
11:06AM  XBIs Large Caps: BioMarin Gives Update on Gene Therapy Study Market Realist
11:02AM  How Does XBI Compare to Its 100-Day Moving Average? Market Realist
Apr-19-16 05:40PM  SPDR Indexes across Energy and Gold Rise on Increase in Commodities
09:06AM  What Do Analysts Recommend for Medivation?
07:10AM  Return Of The Mack: This Biotech ETF Is Back
Apr-18-16 05:18PM  Recovery in Crude Prices Lifts Energy and Healthcare SPDR Indexes
Apr-15-16 10:39AM  XBI Holdings Finished Strong as Market Bounced Back on April 13
Apr-14-16 04:56PM  US Dollar Is Strong despite Inflation Releasing below Forecast
02:46PM  Analyst Estimates for Ionis Pharmaceuticals 2016 Revenue
Apr-11-16 03:14PM  Large-Cap News: Edwards Surged on SAPIENT 3 TAVR Data
03:14PM  Among Biotechnology ETFs, XBI Dominated the 1st Week of April
Apr-09-16 12:06AM  XBI Mid Caps: Alnylam to Present at Needham Healthcare Conference
Apr-08-16 11:18PM  Last Week's Best Healthcare ETF at Motley Fool
Apr-07-16 04:07PM  Incyte Continues Its Growth Spree in 2015
03:04PM  XBI Large Caps: Incyte Signs Deal with Eli Lilly
12:30PM  A Leader-Laggard Long-Short ETF Pair Trade
11:30AM  Biotech Regain Health: ETFs to Prescribe
Apr-06-16 08:15AM  Inklings Of Upside For A Leveraged Biotech ETF +7.02%
Apr-05-16 03:02PM  US Markets Fall despite Rising Non-Manufacturing PMI
02:50PM  Dont Buy The Greatest Fools Theory Of Investment Value
10:36AM  Biotechnology ETFs: Who Were the Top Performers Last Week?
09:40AM  Broad weakness at open: Pisani
Apr-02-16 03:06PM  Why You Should Exercise Caution When Investing in Healthcare
12:30PM  Looking for Sunshine in Biotech's Gloomy First-Quarter Performance at TheStreet
12:13PM  Last Week's Best Healthcare ETF at Motley Fool
Apr-01-16 05:13PM  Positive Market Sentiment as Non-Farm Payroll Beats Expectations
01:08PM  Will Elagolix Make Neurocrine Biosciences a Key Womens Health Name?
12:52PM  Why It's Been a Wild Few Days for Genocea Biosciences Inc. at Motley Fool
Mar-31-16 04:39PM  US Markets Flat as Unemployment Claims Rise
12:07PM  This Indicator Suggests A Bear Market Is Now Underway And Its Likely To Be A Painful One
09:54AM  Biotech Stocks Offer a Greater Risk-to-Reward Trade-Off
09:54AM  Yellens Caution Led Battered Healthcare Up 1.2% on March 29
Mar-29-16 07:06PM  XBI Mid-Cap News: Look Who Took a Beating on March 23
12:56PM  Why It Still Feels Like We're in a Bear Market: Risk Sentiment Is Nowhere to Be Found at TheStreet
Mar-24-16 06:23PM  XBI Large-Cap News: Amid Beatdowns, Regeneron Has an Announcement
06:23PM  Whats Got XBI Down?
11:39AM  US Markets Traded Low as Commodity Prices Fell
Mar-23-16 09:00AM  Trader's Notebook: Biotech Has Momentum -5.01%
Mar-22-16 04:19PM  US Markets Rebound after Brussels Attack: Gold Trades Higher
01:28PM  Curb Your Enthusiasm With the Biotech Bounce at Investopedia
01:05AM  XBI News as of March 16: Mid-Caps Under Pressure
Mar-21-16 12:35PM  Biotech ETFs Show Encouraging Sign; Gold ETF Continues To Struggle
Mar-17-16 01:42PM  XBI on a Downward Slope, but How Steep?
Mar-16-16 06:35PM  FOMC: Less Hawkish Stance amid Concerns about Global Growth
09:00AM  Trader's Notebook: Get Ready for the Old FOMC 'Reverse'
07:00AM  The Trader Daily: Valeant's Crash Scatters Debris
Mar-15-16 05:17PM  US Markets Dip as Retail Sales Fall before FOMC Meeting -5.78%
Mar-14-16 06:55PM  Gold ETF Slumps As Major Indexes Finish Mixed; IBB In Sell Range
04:48PM  US Markets Show Marginal Gains as Investors Display Caution
Mar-10-16 09:00AM  Trader's Notebook: I Favor a More Bearish Posture on Miners
05:58AM  Gilead Sciences Is a Buy Now at TheStreet
Mar-09-16 04:04PM  Energy and Mining SPDR Funds Rally as Precious Metals Exhibit Decline
Mar-08-16 09:00AM  Trader's Notebook: Is It Time to Short Netflix and Facebook? -5.22%
06:55AM  What Led Advaxis to Top XBI with a 49% Gain?
Mar-07-16 08:07AM  XBIs Mid-Cap Stocks Outperformed Large Caps
Mar-05-16 02:00PM  Last Week's Best Healthcare ETF at Motley Fool
12:00PM  So Many Topics, So Few Columns
Mar-04-16 09:00AM  Trader's Notebook: Is It Biotech's Turn to Outperform?
Mar-03-16 06:19PM  Your first trade for Friday, March 4 at CNBC
05:58PM  Final Trade: Apple, The Fresh Market, & more
03:03PM  Energy and Mining SPDRs Rally as Services Sector Declines
Mar-02-16 04:10PM  Biotech: 'A Crowded Trade in the Midst of Unwinding' at
Mar-01-16 03:01PM  Upbeat Macro Releases: Enough for a Rally in Banking SPDRs?
09:00AM  Trader's Notebook: No Cure for Biotechs Ills
Feb-29-16 09:43PM  Is The Biotech Bear Market Over? at Forbes
Feb-26-16 04:14PM  Banking SPDRs Got a Boost while Utility ETFs Traded Lower
Feb-25-16 08:07AM  XBIs Large-Cap Stocks Ended Lower: How Did They Perform?
Feb-24-16 11:02AM  How Did Ziopharm Keep XBI from Losing More Ground?
11:00AM  Biotech Investors Shouldn't Fear Legislation, Even If Hillary Is President And Dems Win Senate Majority
Feb-19-16 08:50AM  Some Traders Aren't Shy About Betting On A Biotech Rebound
Feb-16-16 01:33PM  Is the worst ETF of 2016 about to get even worse? at CNBC
Feb-09-16 08:14PM  Transportation, Jets ETFs Speed Up As Oil Falls Below $28
05:46PM  Why Keryx Biopharmaceuticals Inc. Plunged 26% in January at Motley Fool
Feb-08-16 02:33PM  Biotech Waiting Game Still Paying Off For Gilead at The Wall Street Journal -5.53%
10:32AM  Why Are Analysts So Bullish On This Tumbling Biotech Company?
07:45AM  Biotech fund gets vote of confidence
Feb-06-16 12:01AM  [$$] Celgene and Gilead: Two Drugmakers, 30% Upside at
Feb-05-16 11:02AM  Some biotechnology stocks that provide clear opportunities, J.P. Morgan says at MarketWatch
09:48AM  ETFs to Play a Pop in Biotech M&A at
Feb-03-16 01:05PM  Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits High
12:48PM  TickerTags Data Shows Drug Price Debate Still Trending
10:17AM  3 Biotech ETFs With Bear-Killing Magic at TheStreet
Feb-02-16 05:40PM  Why Regeneron Pharmaceuticals Shares Fell 23% in January at Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS Medical Breakthroughs ETF and BioShares Biotechnology Clinical Trials Fund
Jan-31-16 02:46PM  Tracking The Biotech Bubble's Bust at Forbes
Jan-29-16 01:17PM  If history rhymes this indicator suggests stocks still have a long way to fall
09:30AM  The Zacks Analyst Blog Highlights: PowerShares DB US Dollar Bullish Fund, SPDR S&P Biotech ETF, SPDR S&P Regional Banking ETF and SPDR Gold Shares
Jan-28-16 11:37AM  ETF Winners & Losers Post Fed Meet
Jan-22-16 08:07AM  Revlimid Continues to Drive Celgenes Revenue
07:11AM  Even With Volatility, Investors Love Biotech ETFs
Jan-20-16 03:53PM  Chimerix Inc. Is Roaring Higher Again -- Here's Why at Motley Fool
Jan-19-16 08:47AM  Calls bet on quick pop in biotech fund
Jan-18-16 08:59AM  Bloodied Biotech Stocks Had It Coming, But Check Out This Chart at Forbes
Jan-16-16 09:12AM  Biotech Investing: This Is Undoubtedly the Craziest Stat You'll Ever See at Motley Fool
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.